- Home
- APLM vs BTBD Comparison
APLM vs BTBD Comparison
Compare APLM & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- BTBD
- Stock Information
- Founded
- APLM 2016
- BTBD 1987
- Country
- APLM United States
- BTBD United States
- Employees
- APLM N/A
- BTBD N/A
- Industry
- APLM Blank Checks
- BTBD Restaurants
- Sector
- APLM Finance
- BTBD Consumer Discretionary
- Exchange
- APLM Nasdaq
- BTBD Nasdaq
- Market Cap
- APLM 6.9M
- BTBD 6.6M
- IPO Year
- APLM N/A
- BTBD 2021
- Fundamental
- Price
- APLM $6.41
- BTBD $1.33
- Analyst Decision
- APLM
- BTBD
- Analyst Count
- APLM 0
- BTBD 0
- Target Price
- APLM N/A
- BTBD N/A
- AVG Volume (30 Days)
- APLM 4.6K
- BTBD 1.3K
- Earning Date
- APLM 08-13-2025
- BTBD 08-12-2025
- Dividend Yield
- APLM N/A
- BTBD N/A
- EPS Growth
- APLM N/A
- BTBD N/A
- EPS
- APLM N/A
- BTBD N/A
- Revenue
- APLM $198,000.00
- BTBD $14,864,398.00
- Revenue This Year
- APLM $415.15
- BTBD N/A
- Revenue Next Year
- APLM N/A
- BTBD N/A
- P/E Ratio
- APLM N/A
- BTBD N/A
- Revenue Growth
- APLM N/A
- BTBD 4.71
- 52 Week Low
- APLM $4.47
- BTBD $1.00
- 52 Week High
- APLM $35.98
- BTBD $2.02
- Technical
- Relative Strength Index (RSI)
- APLM 51.61
- BTBD 50.71
- Support Level
- APLM $5.34
- BTBD $1.28
- Resistance Level
- APLM $6.70
- BTBD $1.36
- Average True Range (ATR)
- APLM 0.52
- BTBD 0.03
- MACD
- APLM -0.03
- BTBD -0.01
- Stochastic Oscillator
- APLM 67.65
- BTBD 41.18
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.